SE406467B - Nytt forfarande for framstellning av bensotiazinforeningar med antiinflammatorisk verkan - Google Patents

Nytt forfarande for framstellning av bensotiazinforeningar med antiinflammatorisk verkan

Info

Publication number
SE406467B
SE406467B SE747405399A SE7405399A SE406467B SE 406467 B SE406467 B SE 406467B SE 747405399 A SE747405399 A SE 747405399A SE 7405399 A SE7405399 A SE 7405399A SE 406467 B SE406467 B SE 406467B
Authority
SE
Sweden
Prior art keywords
bensotiazine
preparing
compounds
inflammatory effect
new procedure
Prior art date
Application number
SE747405399A
Other languages
English (en)
Swedish (sv)
Inventor
J G Lombardino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE406467B publication Critical patent/SE406467B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE747405399A 1973-04-23 1974-04-22 Nytt forfarande for framstellning av bensotiazinforeningar med antiinflammatorisk verkan SE406467B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00353607A US3853862A (en) 1973-04-23 1973-04-23 Production of 4-hydroxy-1,2-benzothiazine-3-carboxamides

Publications (1)

Publication Number Publication Date
SE406467B true SE406467B (sv) 1979-02-12

Family

ID=23389837

Family Applications (1)

Application Number Title Priority Date Filing Date
SE747405399A SE406467B (sv) 1973-04-23 1974-04-22 Nytt forfarande for framstellning av bensotiazinforeningar med antiinflammatorisk verkan

Country Status (21)

Country Link
US (3) US3853862A (US06312121-20011106-C00033.png)
JP (1) JPS5760347B2 (US06312121-20011106-C00033.png)
AR (1) AR205249A1 (US06312121-20011106-C00033.png)
AT (1) AT333777B (US06312121-20011106-C00033.png)
CA (1) CA1018525A (US06312121-20011106-C00033.png)
CH (1) CH590257A5 (US06312121-20011106-C00033.png)
CS (1) CS165311B2 (US06312121-20011106-C00033.png)
DD (1) DD111079A5 (US06312121-20011106-C00033.png)
DK (1) DK140014B (US06312121-20011106-C00033.png)
ES (1) ES425398A1 (US06312121-20011106-C00033.png)
FI (1) FI52087C (US06312121-20011106-C00033.png)
GB (1) GB1414887A (US06312121-20011106-C00033.png)
HU (1) HU170489B (US06312121-20011106-C00033.png)
IE (1) IE39119B1 (US06312121-20011106-C00033.png)
LU (1) LU69905A1 (US06312121-20011106-C00033.png)
NL (1) NL7405413A (US06312121-20011106-C00033.png)
PL (1) PL90468B1 (US06312121-20011106-C00033.png)
RO (1) RO63727A (US06312121-20011106-C00033.png)
SE (1) SE406467B (US06312121-20011106-C00033.png)
SU (1) SU552030A3 (US06312121-20011106-C00033.png)
YU (1) YU39152B (US06312121-20011106-C00033.png)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954786A (en) * 1974-04-19 1976-05-04 Pfizer Inc. Isoxazole intermediate compounds
US3900470A (en) * 1974-09-23 1975-08-19 Mcneilab Inc Esters of benzothiazine-1,1-dioxides derivatives
US3923801A (en) * 1974-09-23 1975-12-02 Mcneilab Inc Oxazinobenzothiazine 6,6-dioxides
US3925371A (en) * 1974-09-23 1975-12-09 Mcneilab Inc Benzothiazine-1,1-dioxides
US3891637A (en) * 1974-10-01 1975-06-24 Pfizer Process for the production of carboxamides of oxo-1,2-benzothiazine-1,1-dioxides
US3892740A (en) * 1974-10-15 1975-07-01 Pfizer Process for the production of carboxamides of oxo-1,2-benzothiazine-1,1-dioxides
US4100347A (en) * 1976-06-10 1978-07-11 Pfizer Inc. 3,4-Dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4217355A (en) * 1978-04-24 1980-08-12 Pfizer Inc. Amide therapeutic agents
JPS5714589A (en) * 1980-06-27 1982-01-25 Mitsui Toatsu Chem Inc Benzothiazine derivative, its preparation and drug composition
JPS57140785A (en) * 1981-02-24 1982-08-31 Mitsui Toatsu Chem Inc Benzothiazine derivative, its preparation, and pharmaceutical composition containing the same
US4289879A (en) * 1980-09-29 1981-09-15 Pfizer Inc. Synthetic method and intermediate for piroxicam
IN158333B (US06312121-20011106-C00033.png) * 1981-08-03 1986-10-18 Pfizer
GT198276334A (es) * 1981-08-03 1984-01-10 Procedimiento e inter-medios para la produccion de carboxamidas de benzotiazina.
IN159273B (US06312121-20011106-C00033.png) * 1981-10-05 1987-04-25 Pfizer
SU1306476A3 (ru) * 1982-06-17 1987-04-23 Пфайзер,Инк (Фирма) Способ получени 2-метил-3- @ -(2-пиридил)-карбамоил-3,4-дигидро-2 @ -1,2-бензтиазин-1,1-диоксида
US4483982A (en) * 1982-09-02 1984-11-20 Pfizer Inc. Processes for preparing piroxicam and intermediates leading thereto
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
JPS6243434U (US06312121-20011106-C00033.png) * 1985-09-03 1987-03-16
JPH0629271B2 (ja) * 1988-03-09 1994-04-20 株式会社日本ハイポックス ベンゾチアジン―1,1―ジオキシド誘導体及びそれを含有する医薬組成物
WO1997046532A1 (en) * 1996-06-03 1997-12-11 Boehringer Ingelheim Pharmaceuticals, Inc. 2-benzyl-4-sulfonyl-4h-isoquinolin-1,3-diones and their use as anti-inflammatory agents
IL155333A0 (en) 2000-10-17 2003-11-23 Applied Res Sulfanilide derivatives for use in medicine, certain such new derivatives and their preparation
US6865910B2 (en) * 2001-12-05 2005-03-15 Emhart Glass S.A. Glass container forming machine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676188A (en) * 1950-12-16 1954-04-20 American Home Prod Acylated glycinamides
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US4062861A (en) * 1973-07-27 1977-12-13 Shionogi & Co., Ltd. 3-Isoxazolylurea derivatives
GB1498884A (en) * 1975-04-15 1978-01-25 Wyeth John & Brother Ltd Aminoacetamide-pyridyl-tetrahydropyridyl and-piperidyl derivatives

Also Published As

Publication number Publication date
DK140014B (da) 1979-06-05
DK140014C (US06312121-20011106-C00033.png) 1979-11-05
AT333777B (de) 1976-12-10
YU112174A (en) 1982-06-30
LU69905A1 (US06312121-20011106-C00033.png) 1974-11-21
JPS5012094A (US06312121-20011106-C00033.png) 1975-02-07
JPS5760347B2 (US06312121-20011106-C00033.png) 1982-12-18
PL90468B1 (US06312121-20011106-C00033.png) 1977-01-31
GB1414887A (en) 1975-11-19
HU170489B (US06312121-20011106-C00033.png) 1977-06-28
FI52087C (fi) 1977-06-10
RO63727A (fr) 1978-12-15
CH590257A5 (US06312121-20011106-C00033.png) 1977-07-29
CA1018525A (en) 1977-10-04
IE39119B1 (en) 1978-08-02
ATA327374A (de) 1976-04-15
ES425398A1 (es) 1976-05-16
AR205249A1 (es) 1976-04-21
NL7405413A (US06312121-20011106-C00033.png) 1974-10-25
DD111079A5 (US06312121-20011106-C00033.png) 1975-01-20
YU39152B (en) 1984-06-30
CS165311B2 (US06312121-20011106-C00033.png) 1975-12-22
US3853862A (en) 1974-12-10
IE39119L (en) 1974-10-23
FI52087B (US06312121-20011106-C00033.png) 1977-02-28
USRE29669E (en) 1978-06-13
USRE29668E (en) 1978-06-13
SU552030A3 (ru) 1977-03-25

Similar Documents

Publication Publication Date Title
SE406467B (sv) Nytt forfarande for framstellning av bensotiazinforeningar med antiinflammatorisk verkan
SE419981B (sv) Forfarande for framstellning av 1alfa-hydroxi-vitamin d-derivat
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
SE453667B (sv) Forfarande for framstellning av polyeterimider
SE415761B (sv) Forfarande for framstellning av hexahydro-dibenso(b,d)pyran-9-on-derivat med terapeutisk verkan
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
SE420201B (sv) Forfarande for framstellning av nya 7alfa-metoxicefalosporinderivat
SE424994B (sv) Forfarande for framstellning av nya pseudotrisackarider
SE416731B (sv) Forfarande for framstellning av nya penicilliner
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
SE407575B (sv) Forfarande for framstellning av 1,3-dioxanderivat med terapentisk verkan
SE413244B (sv) Forfarandefor framstellning av bensopyraner med analgetisk verkan
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE415255B (sv) Forfarande for framstellning av furoylettiksyra - derivat med hypolipidemisk verkan
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
SE421129B (sv) Forfarande for framstellning av poly-n-alkyl-iminoalaner
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
FI55498C (fi) Foerfarande foer framstaellning av hypoglycemiska pyridinkarboxamid-sulfonylureafoereningar

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7405399-2

Effective date: 19940510

Format of ref document f/p: F